How stress affects brain reward systems and dopamine signaling
The Impact of Stress-induced KCC2 Downregulation on Mesolimbic Dopamine Signaling and Reward Processing
This study is looking at how stress affects the brain's reward system, especially how a specific protein helps manage dopamine signals when we're under stress, and it's designed for anyone interested in understanding more about how stress can impact mental health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgetown University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-10973193 on NIH RePORTER |
What this research studies
This research investigates how environmental stress impacts the brain's reward systems, particularly focusing on the mesolimbic pathway, which includes key areas like the ventral tegmental area and nucleus accumbens. The study examines the role of a specific anion transporter, KCC2, in regulating dopamine signaling and reward processing in response to stress. Using rodent models, the researchers will analyze how stress-induced changes in GABAergic signaling affect dopamine neuron activity and reward-related behaviors. The findings aim to enhance our understanding of the neurobiological mechanisms underlying stress-related psychiatric disorders.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals experiencing stress-related psychological issues or disorders.
Not a fit: Patients with non-stress-related psychiatric conditions may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating stress-related neuropsychiatric disorders.
How similar studies have performed: Previous research has shown promising results in understanding the role of stress in neuropsychiatric disorders, but this specific approach focusing on KCC2 and dopamine signaling is relatively novel.
Where this research is happening
Washington, United States
- Georgetown University — Washington, United States (Active)
Researchers
- Principal investigator: Ostroumov, Alexey — Georgetown University
- Study coordinator: Ostroumov, Alexey
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.